comparemela.com

Latest Breaking News On - Aortic valve replacement - Page 2 : comparemela.com

Eye on Health: Saving Lives with TAVR

There is a procedure being done in our community, and doctors call it a game-changer when it comes to your heart. This is American Heart Month, and in this Eye

United statesTroy weirickSusan behlingAmjad syedLeanne tokarsBeacon health systemEye on healthAmerican heart monthJerry weaverTranscatheter aortic valveBeacon healthcare systemGeneral hospitalHealth medical pharmaCarelon behavioral healthElevance healthBeacon health

Edwards Lifesciences Reports Fourth Quarter Results

Edwards Lifesciences today reported financial results for the quarter ended December 31, 2023. Highlights and Outlook Q4 sales grew 14 percent to $1.53 billion; constant currency1 sales grew 13.

United statesEdwards lifesciencesBernard zovighianDrug administrationProgram discontinuationEdwards lifesciences corporationExchange commissionMedtronic incSecurities exchangeProduct groupAortic valve replacementTricuspid therapiesStructural heartSmart recoveryHypotension prediction indexSecurities act

Global Structural Heart Devices Market Analysis & Forecast 2024-2034: Implications for Global Healthcare and Patient Outcomes

/PRNewswire/ The "Global Structural Heart Devices Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com s offering..

United statesUnited kingdomAsia pacificBraile biomedicaLaura woodInterventional devices incBoston scientific corporationE st office hours callAbbott laboratoriesEdwards lifesciences corporationJenavalve technology incCryolife incJude medical incSurgical centersOffice hours callTechnology est

Global Structural Heart Devices Market Set for Remarkable

Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) The

United kingdomUnited statesAsia pacificBraile biomedicaBoston scientific corporationTechnology estSurgical centersJenavalve technology incAbbott laboratoriesEdwards lifesciences corporationJude medical incCryolife incInterventional devices incStructural heart devices market analysisNorth americaGlobal healthcare

Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese domestic player in the high-growth transcatheter

John kilcoyneMichael zhangPeijia medical limitedJenavalve technology incNational medical products administrationAortic valve replacementValve systemAortic regurgitationJenavalve technologyGreater chinaChief executive officerLate breaking clinical trialCardiovascular therapeuticsAnnual scientific symposium

vimarsana © 2020. All Rights Reserved.